A Study of Children With Refractory or Relapsed ALL
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to find out which form of asparaginase (the native E.
coli/Erwinia) or PEG-asparaginase) is more effective during induction treatment for children
with acute lymphoblastic leukemia that has come back after treatment (relapsed) or is
resistant to treatment (refractory)